VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 52 filers reported holding VERRICA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,814 | -32.7% | 2,526 | 0.0% | 0.00% | – |
Q2 2023 | $14,575 | +628.8% | 2,526 | +129.2% | 0.00% | – |
Q2 2022 | $2,000 | -83.3% | 1,102 | -23.3% | 0.00% | – |
Q1 2022 | $12,000 | -7.7% | 1,437 | 0.0% | 0.00% | – |
Q4 2021 | $13,000 | -27.8% | 1,437 | 0.0% | 0.00% | – |
Q3 2021 | $18,000 | +12.5% | 1,437 | 0.0% | 0.00% | – |
Q2 2021 | $16,000 | -27.3% | 1,437 | 0.0% | 0.00% | – |
Q1 2021 | $22,000 | +22.2% | 1,437 | -8.0% | 0.00% | – |
Q4 2020 | $18,000 | +50.0% | 1,562 | 0.0% | 0.00% | – |
Q3 2020 | $12,000 | -50.0% | 1,562 | -27.7% | 0.00% | – |
Q2 2020 | $24,000 | +14.3% | 2,160 | +13.6% | 0.00% | – |
Q1 2020 | $21,000 | -46.2% | 1,902 | -23.2% | 0.00% | – |
Q4 2019 | $39,000 | +39.3% | 2,476 | +31.3% | 0.00% | – |
Q3 2019 | $28,000 | +55.6% | 1,886 | 0.0% | 0.00% | – |
Q2 2019 | $18,000 | -10.0% | 1,886 | 0.0% | 0.00% | – |
Q1 2019 | $20,000 | +185.7% | 1,886 | +112.1% | 0.00% | – |
Q4 2018 | $7,000 | -50.0% | 889 | 0.0% | 0.00% | – |
Q3 2018 | $14,000 | – | 889 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 256,244 | $3,203,000 | 0.84% |
Perceptive Advisors | 3,610,412 | $45,130,000 | 0.66% |
Orbimed Advisors | 1,479,733 | $18,497,000 | 0.20% |
Fosun International Ltd | 282,408 | $3,530,000 | 0.18% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 728,236 | $9,103,000 | 0.14% |
SteelPeak Wealth, LLC | 133,161 | $1,665,000 | 0.11% |
HighVista Strategies LLC | 10,944 | $137,000 | 0.09% |
Capital Investment Advisory Services, LLC | 15,125 | $189,000 | 0.02% |
MML INVESTORS SERVICES, LLC | 44,875 | $561,000 | 0.00% |
BECK MACK & OLIVER LLC | 10,000 | $125,000 | 0.00% |